Results 271 to 280 of about 201,576 (315)
Some of the next articles are maybe not open access.

Mixed connective tissue disease

Clinics in Dermatology, 1985
Abstract Mixed connective tissue disease (MCTD) was first described by Gordon Sharp, 1 in 1972, as a distinct connective tissue disorder characterized by overlapping features of systemic lupus erythematosus (SLE), progressive systemic sclerosis (PSS), and dermato/polymyositis (DP/PM).
D T, Schreiner, J L, Jorizzo
openaire   +2 more sources

Connective Tissue Diseases and the Heart

JAMA: The Journal of the American Medical Association, 1975
CONNECTIVE tissue disease is a term used to describe any one of a group of rheumatoid disorders of uncertain cause, which have overlapping clinical manifestations and may share common mechanisms of pathogenesis. The diseases included in the discussion are rheumatoid arthritis, systemic lupus erythematosus (SLE), progressive systemic sclerosis (PSS ...
openaire   +2 more sources

Mixed Connective Tissue Disease

AJN, American Journal of Nursing, 1977
Coping with chronic illness has become a personal experience for me. For the past 13 years, I have gone through various stages of coping with mixed connective tissue disease (MCTD), a rare collagen-vascular disease of unknown origin that resembles scleroderma, lupus erythematosus, and polymyositis.
openaire   +4 more sources

Undifferentiated connective tissue disease

Orvosi Hetilap, 2009
Evolution of immunopathological diseases is usually slow and progressive. Non-differentiated collagen disease (NDC) or the term “undifferentiated connective tissue disease” (UCTD) represents a stage of disease where clinical symptoms and serological abnormalities suggest autoimmune disease, but they are not sufficient to fulfill the diagnostic ...
Edit, Bodolay, Gyula, Szegedi
openaire   +2 more sources

The Cornea in Connective Tissue Diseases

Ophthalmology, 1978
Even though lenticular and retinal abnormalities seem to dominate the ophthalmologic picture in Marfan's syndrome, the cornea shows significant abnormalities consisting of a striking flattening and corneal astigmatism. The use of conjunctival biopsies followed by histochemical and electron-microscopic evaluation shows low morbidity but an excellent ...
openaire   +2 more sources

Mixed connective tissue disease

Best Practice & Research Clinical Rheumatology, 2016
The concept of mixed connective tissue disease (MCTD) as a separate connective tissue disease (CTD) has persisted for more than four decades. High titers of antibodies targeting the U1 small nuclear ribonucleoprotein particle (U1 snRNP) in peripheral blood are a sine qua non for the diagnosis of MCTD, in addition to distinct clinical features including
Ragnar, Gunnarsson   +3 more
openaire   +2 more sources

Connective Tissue Disease in Children

Pediatric Annals, 2005
As our understanding of connective tissue disease expands, so too does our therapeutic armamentarium. We have learned that autoimmunity triggers inflammation through unchecked, proliferative cell-mediated inflammation. By targeting this arm of the cytokine cascade, it may be possible to arrest further progression.
Robert L, Buka, Bari B, Cunningham
openaire   +2 more sources

Connective Tissue Disease in the Elderly

Clinics in Rheumatic Diseases, 1986
The prevalence of the inflammatory disorders of connective tissue in the older age group is quite likely underestimated at the present time; and, in most instances, age-related factors influencing clinical expression and autoreactivity have not been intensively studied. The array of connective tissue disease that usually targets the young adult emerges
openaire   +2 more sources

Connective Tissue Diseases

Best Practice & Research Clinical Rheumatology, 2007
Furst DE, MATUCCI CERINIC, MARCO
openaire   +2 more sources

Connective tissue diseases

Journal of the American Academy of Dermatology, 1984
S R, Pinnell   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy